Rel-(2R,6S)-4-(6-chloro-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine

Catalog No.: 
ACYTVS880
CAS No.: 
1592651-04-1
Molecular Formula: 
C11H16ClN3O
Molecular Weight: 
241.72
Rel-(2R,6S)-4-(6-chloro-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$405.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-(2R,6S)-4-(6-chloro-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine
IUPAC Name(2R,6S)-4-(6-chloro-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine
Molecular FormulaC11H16ClN3O
Molecular Weight241.72
SMILESC[C@@H]1O[C@H](C)CN(C2=NC(C)=NC(Cl)=C2)C1
InChI KeyDHYMBQRDHIJTBH-OCAPTIKFSA-N
SynonymMorpholine, 4-(6-chloro-2-methyl-4-pyrimidinyl)-2,6-dimethyl-, (2R,6S)-rel-;(2s,6r)-4-(6-chloro-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine;(2R,6S)-4-(6-chloro-2-methylpyrimidin-4-yl)-2,6-dimethylmorpholine - [AC80583]
CAS No.1592651-04-1

Synthetic Route by SureRoute

1. ACYTVS880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFUEM270 route compound structure diagram
    ACFUEM2701780-26-3In Stock
  4. Then
  5. ACYTVS880 route product structure diagram
    ACYTVS8801592651-04-1
Inquiry

2. ACYTVS880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTVS880 route product structure diagram
    ACYTVS8801592651-04-1
Inquiry

3. ACYTVS880 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYTVS880 route product structure diagram
    ACYTVS8801592651-04-1
Inquiry

Comments (0)